Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenoid cystic carcinoma
(
ACC
) is characterized by persistent, relentless growth and a high rate of eventual metastasis. In contrast, polymorphous low-grade adenocarcinoma (PLGA) has a much lower risk of recurrence and rarely metastasizes. The histologic patterns of these two neoplasms can be similar. Expression of c-kit, a transmembrane receptor tyrosine kinase, has recently been reported to be expressed in
ACC
but not PLGA. Expression of
galectin-3
, a nonintegrin beta-galactosidase-binding lectin, has been reported to be significant in PLGA and decreased in
ACC
.Formalin-fixed paraffin-embedded tissue from 9
ACC
and 14 PLGA were immunostained for c-kit and
galectin-3
. Cases were scored as 1+ (5-25% positive), 2+ (26-50% positive), or 3+ (>50% positive). C-kit was expressed by 100% of
ACC
(3+: 7 cases; 2+: 1 case; 1+: 1 case) and by 57% of PLGA (2+: 2 cases; 1+: 6 cases). In all but one
ACC
, c-kit expression was confined to the inner cell layer. C-kit expression was also noted in the intercalated duct epithelium of the salivary glands and the acinar cells of the lacrimal gland.
Galectin-3
was expressed in 8 of 9 cases of
ACC
and 14 of 14 cases of PLGA. The results of this, the first study to compare c-kit and
galectin-3
expression in
ACC
and PLGA, suggest that c-kit expression characterizes
ACC
, but not PLGA.
Galectin-3
immunohistochemistry does not have a role in the differentiation of
ACC
and PLGA. C-kit immunostaining may be a valuable adjunctive tool for this differential diagnosis, particularly in the setting of a limited biopsy. Our finding of different patterns of c-kit expression in tubular and solid variants of
ACC
supports the concept of solid variant
ACC
as a high-grade tumor, with progression toward an entirely "inner cell" phenotype.
...
PMID:C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. 1211 4
Adenoid cystic carcinoma
(
ACC
) and polymorphous low-grade adenocarcinoma (PLGA) are malignant neoplasms of salivary glands, which are similar in histologic patterns but very different in clinical behavior, treatment and prognosis.
Galectin-3
is a multifunctional protein of a growing family of beta-galactoside-binding animal lectins, which is implicated in a variety of biological events such as tumor cell adhesion, proliferation, differentiation and angiogenesis. This protein was found to be implicated in cellular transformation and a correlation between its expression and cancer progression and metastasis has been described. The aim of this study was to determine the
galectin-3
immunoprofile in 14 cases of
ACC
(2 cases of tubular subtype, 4 cases of solid subtype and 8 cases of cribriform subtype) and in 12 cases of PLGA with different histologic patterns, including lobular, tubular and cribriform aspects. Moreover, slides of normal salivary glands were included. In normal salivary glands there was strong nuclear and cytoplasmic staining for
galectin-3
in ductal luminal cells.
ACC
showed specific staining in luminal cells mainly in the nuclei. In the tubular subtype of
ACC
,
galectin-3
strongly stained luminal cells of the ductiform structures. The cribriform and solid subtypes showed a few positive luminal cells of small ducts present in the cribriform structures and in solid nests respectively. In the cases of PLGA, independent of the histologic architecture, all tumor cells revealed a positive cytoplasmic reaction.
Galectin-3
expression seems to be related to cell differentiation more than to tumor progression and prognosis in the neoplasms studied.
...
PMID:Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. 1699 82